| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
5 |
/ |
2021 |
|
|
|
| |
Data sporządzenia: |
2021-01-21 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Receiving a Notice of Allowance for U.S Patent Related to CompuFlo Disposables |
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_,
today announced that Milestone Scientific, Inc. _NYSE:MLSS_, the licensor and the
majority shareholder of the Issuer has received a Notice of Allowance from the United
States Patent and Trademark Office _USPTO_ for a patent relating to the disposable
component of Milestone’s CompuFlo® Instrument.
The Board of Directors of the Company commented that the Issuer’s clinical objectives
have always been to focus on creating greater control and safety of its disposables.
This aligns with the Company’s commercial strategy to ensure its disposables are protected
due to the high margin, recurring revenue nature of these sales. This patent will
cover the unique interactions of the disposable assembly and a micro-chip security
verification feature embedded in the disposables, which provides numerous clinical
and safety benefits for the patient and practitioner. This patent also covers the
use of an embedded security chip, which is intended to enhance the safety and integrity
of its system by preventing improper reuse of the disposables, as well as ensuring
its instrument can only be used with authenticated disposables for the current and
future systems. The Board of Directors of the Company believes that ensuring the
use of only authorized disposable components is critical to CompuFlo’s performance,
safety as well as the long-term financial success of the Company. The Board of Directors
of the Company is proud to state that Milestone Scientific, the licensor and the majority
shareholder of the Issuer currently holds more than 20 patents surrounding the injection
and drug delivery systems, which further solidifies its leadership position in this
market.
|
|
|
RB_ASO: Receiving a Notice of Allowance for U.S Patent Related to CompuFlo Disposables
